East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Prednisone Tablets USP, 1mg. Aurobindo Pharma’s Prednisone Tablets USP, 1mg, are an AB-rated generic equivalent to the reference listed drug (RLD), Meticorten® Tablets, of Schering Corp Sub Schering Plough Corp.

Prednisone Tablets are indicated in the following conditions:

• Endocrine Disorders
• Rheumatic Disorders
• Collagen Diseases
• Dermatologic Diseases
• Allergic States
• Ophthalmic Diseases
• Respiratory Diseases
• Hematologic Disorders
• Neoplastic Diseases
• Edematous States
• Gastrointestinal Diseases
• Tuberculous meningitis with subarachnoid block or impending block when used concurrently with appropriate antituberculous chemotherapy; trichinosis with neurologic or myocardial involvement.